These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 12795778)

  • 1. Use of gabexate mesylate in Italian hospitals: a multicentre observational study.
    Pelagotti F; Cecchi M; Messori A;
    J Clin Pharm Ther; 2003 Jun; 28(3):191-6. PubMed ID: 12795778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gabexate for the prevention of pancreatic damage related to endoscopic retrograde cholangiopancreatography. Gabexate in digestive endoscopy--Italian Group.
    Cavallini G; Tittobello A; Frulloni L; Masci E; Mariana A; Di Francesco V
    N Engl J Med; 1996 Sep; 335(13):919-23. PubMed ID: 8786777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabexate in the prophylaxis of post-ERCP pancreatitis: a meta-analysis of randomized controlled trials.
    Zheng M; Chen Y; Yang X; Li J; Zhang Y; Zeng Q
    BMC Gastroenterol; 2007 Feb; 7():6. PubMed ID: 17295917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombin III in patients admitted to intensive care units: a multicenter observational study.
    Messori A; Vacca F; Vaiani M; Trippoli S;
    Crit Care; 2002 Oct; 6(5):447-51. PubMed ID: 12398786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis.
    Andriulli A; Leandro G; Federici T; Ippolito A; Forlano R; Iacobellis A; Annese V
    Gastrointest Endosc; 2007 Apr; 65(4):624-32. PubMed ID: 17383459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect and cost of treatment for acute pancreatitis with or without gabexate mesylate: a propensity score analysis using a nationwide administrative database.
    Yasunaga H; Horiguchi H; Hashimoto H; Matsuda S; Fushimi K
    Pancreas; 2013 Mar; 42(2):260-4. PubMed ID: 23000890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a multicenter, placebo-controlled, randomized clinical trial.
    Andriulli A; Clemente R; Solmi L; Terruzzi V; Suriani R; Sigillito A; Leandro G; Leo P; De Maio G; Perri F
    Gastrointest Endosc; 2002 Oct; 56(4):488-95. PubMed ID: 12297762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gabexate mesilate and acute pancreatitis: an experience of evidence based drug information for improving rational drug use.
    Banfi R; Borselli G; Cappelletti S; Mari L; Aiazzi M; Taddei V
    Pharm World Sci; 2005 Apr; 27(2):121-3. PubMed ID: 15999923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Somatostatin, Ulinastatin and Gabexate on the Treatment of Severe Acute Pancreatitis.
    Wang G; Liu Y; Zhou SF; Qiu P; Xu L; Wen P; Wen J; Xiao X
    Am J Med Sci; 2016 May; 351(5):506-12. PubMed ID: 27140710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis.
    Andriulli A; Leandro G; Niro G; Mangia A; Festa V; Gambassi G; Villani MR; Facciorusso D; Conoscitore P; Spirito F; De Maio G
    Gastrointest Endosc; 2000 Jan; 51(1):1-7. PubMed ID: 10625786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of postprocedure administration of gabexate mesylate in the prevention of post-ERCP pancreatitis: a randomized, controlled, multicenter study.
    Manes G; Ardizzone S; Lombardi G; Uomo G; Pieramico O; Porro GB
    Gastrointest Endosc; 2007 Jun; 65(7):982-7. PubMed ID: 17531632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequency of post-ERCP pancreatitis in a single tertiary referral centre without and with routine prophylaxis with gabexate: a 6-year survey and cost-effectiveness analysis.
    Testoni PA; Mariani A; Masci E; Curioni S
    Dig Liver Dis; 2006 Aug; 38(8):588-95. PubMed ID: 16731060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of gabexate mesilate for acute pancreatitis in children.
    Kim SC; Yang HR
    Eur J Pediatr; 2013 Nov; 172(11):1483-90. PubMed ID: 23812506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multicentre comparative study of two schedules of gabexate mesilate in the treatment of acute pancreatitis. Italian Acute Pancreatitis Study Group.
    Pezzilli R; Miglioli M
    Dig Liver Dis; 2001; 33(1):49-57. PubMed ID: 11303975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rectal indomethacin or intravenous gabexate mesylate as prophylaxis for acute pancreatitis post-endoscopic retrograde cholangiopancreatography.
    Guglielmi V; Tutino M; Guerra V; Giorgio P
    Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5268-5274. PubMed ID: 29228444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective and randomized study of gabexate mesilate for the treatment of severe acute pancreatitis with organ dysfunction.
    Chen HM; Chen JC; Hwang TL; Jan YY; Chen MF
    Hepatogastroenterology; 2000; 47(34):1147-50. PubMed ID: 11020900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is protease inhibitor a choice for the treatment of pre- or mild disseminated intravascular coagulation?
    Nishiyama T; Matsukawa T; Hanaoka K
    Crit Care Med; 2000 May; 28(5):1419-22. PubMed ID: 10834689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of gabexate mesilate in acute pancreatitis. A metaanalysis.
    Messori A; Rampazzo R; Scroccaro G; Olivato R; Bassi C; Falconi M; Pederzoli P; Martini N
    Dig Dis Sci; 1995 Apr; 40(4):734-8. PubMed ID: 7720462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of gabexate mesilate, a protease inhibitor, on human sphincter of Oddi motility.
    Di Francesco V; Mariani A; Angelini G; Masci E; Frulloni L; Talamini G; Passaretti S; Testoni P; Cavallini G
    Dig Dis Sci; 2002 Apr; 47(4):741-5. PubMed ID: 11991602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gabexate mesilate in human acute pancreatitis. German Pancreatitis Study Group.
    Büchler M; Malfertheiner P; Uhl W; Schölmerich J; Stöckmann F; Adler G; Gaus W; Rolle K; Beger HG
    Gastroenterology; 1993 Apr; 104(4):1165-70. PubMed ID: 8462805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.